Caladrius Bio (CLBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLBS | BMY | AMGN | GSK | GILD |
| Company | Caladrius Bio | Bristol-Myers Squibb Company | Amgen Inc | Gsk Plc ADR | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NASDAQ |
| Open | 9.7200 | 47.61 | 273.51 | 41.06 | 67.43 |
| High | 9.7500 | 47.61 | 273.51 | 41.06 | 67.43 |
| Low | 5.7300 | 47.61 | 273.51 | 41.06 | 67.43 |
| Last | 6.3960 | 46.57 | 273.04 | 41.04 | 67.21 |
| Change | -1.2585 | -2.29 | +0.03 | +0.18 | +0.13 |
| % Change | -16.44% | -4.69% | +0.01% | +0.44% | +0.19% |
| Volume | 1,796,440 | 210,427 | 1,155 | 14,517 | 8,471 |
| 20-Day Average Volume | 1,469,975 | 10,615,751 | 2,059,948 | 2,825,001 | 6,103,583 |
| Previous Close | 7.6545 | 48.86 | 273.01 | 40.86 | 67.08 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.5057 | 50.08 | 270.91 | 40.87 | 68.79 |
| 20-Day Raw Stochastic | 16.57% | 0.00% | 46.01% | 46.86% | 19.20% |
| 20-Day Relative Strength | 32.97% | 36.21% | 48.72% | 49.34% | 35.24% |
| Weighted Alpha | -64.50 | -28.64 | +11.43 | +16.06 | -20.20 |
| Today's Opinion | 88% Sell | 88% Sell | 40% Sell | 56% Buy | 100% Sell |
| Previous Opinion | 88% Sell | 88% Sell | 40% Sell | 40% Buy | 100% Sell |
| Last Month's Opinion | 72% Sell | 8% Sell | 24% Buy | 100% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -16.39% since 09/07/22 | -1.43% since 04/18/24 | +4.10% since 04/18/24 | +4.56% since 04/18/24 | +1.92% since 04/18/24 |
| Low | 0.3820 on 09/14/22 | 47.61 on 04/25/24 | 260.68 on 04/19/24 | 39.37 on 04/19/24 | 66.16 on 04/19/24 |
| High | 0.6500 on 09/14/22 | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 41.26 on 04/23/24 | 67.68 on 04/23/24 |
| 1-Month | |||||
| %Chg | -20.63% since 08/12/22 | -8.88% since 03/25/24 | -2.60% since 03/25/24 | -4.13% since 03/25/24 | -7.10% since 03/25/24 |
| Low | 0.3820 on 09/14/22 | 47.61 on 04/25/24 | 260.68 on 04/19/24 | 39.15 on 04/18/24 | 65.90 on 04/18/24 |
| High | 0.6500 on 09/14/22 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 43.22 on 03/28/24 | 73.87 on 03/28/24 |
| 3-Month | |||||
| %Chg | -14.72% since 06/14/22 | -4.03% since 01/25/24 | -11.84% since 01/25/24 | +5.72% since 01/25/24 | -15.95% since 01/25/24 |
| Low | 0.3820 on 09/14/22 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 38.86 on 01/29/24 | 65.90 on 04/18/24 |
| High | 0.6500 on 09/14/22 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 43.84 on 03/07/24 | 80.51 on 01/26/24 |
| 6-Month | |||||
| %Chg | -34.40% since 03/14/22 | -15.90% since 10/25/23 | +0.50% since 10/25/23 | +13.90% since 10/25/23 | -13.98% since 10/25/23 |
| Low | 0.3820 on 09/14/22 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 33.67 on 11/02/23 | 65.90 on 04/18/24 |
| High | 0.7960 on 03/24/22 | 55.29 on 10/26/23 | 329.72 on 02/05/24 | 43.84 on 03/07/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 25,833 | 99,027,448 | 146,436,016 | 84,679,904 | 83,519,768 |
| Shares Outstanding, K | 60,583 | 2,026,759 | 536,376 | 2,072,440 | 1,245,077 |
| Annual Sales | 0 | 45,006,000,000 | 28,190,000,000 | 37,725,000,000 | 27,116,000,000 |
| Annual Net Income | -27,470,000 | 8,025,000,000 | 6,717,000,000 | 6,129,940,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 11,477,000,000 | 8,196,000,000 | 9,980,060,000 | 7,114,000,000 |
| Last Quarter Net Income | -6,630,000 | 1,762,000,000 | 767,000,000 | 433,200,000 | 1,429,000,000 |
| 60-Month Beta | 0.91 | 0.39 | 0.58 | 0.64 | 0.19 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.11 on 08/04/22 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 0.72 on 01/31/24 | 1.72 on 02/06/24 |
| Latest Earnings Date | 11/03/22 | 04/25/24 | 05/02/24 | 05/01/24 | 04/25/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.397 on 02/22/24 | 0.770 on 03/14/24 |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 02/22/24 | 03/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.53 | 14.67 | 10.71 | 9.97 |